State Street’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.23M Sell
3,107,719
-390,570
-11% -$280K ﹤0.01% 3268
2025
Q1
$5.14M Sell
3,498,289
-4,830,528
-58% -$7.1M ﹤0.01% 2873
2024
Q4
$36.9M Sell
8,328,817
-1,591,048
-16% -$7.05M ﹤0.01% 1870
2024
Q3
$40.9M Buy
9,919,865
+677,024
+7% +$2.79M ﹤0.01% 1804
2024
Q2
$60.3M Sell
9,242,841
-4,674,270
-34% -$30.5M ﹤0.01% 1570
2024
Q1
$121M Buy
13,917,111
+2,385,023
+21% +$20.8M 0.01% 1184
2023
Q4
$132M Sell
11,532,088
-464,777
-4% -$5.32M 0.01% 1112
2023
Q3
$116M Buy
11,996,865
+968,376
+9% +$9.33M 0.01% 1090
2023
Q2
$117M Buy
11,028,489
+546,647
+5% +$5.82M 0.01% 1107
2023
Q1
$110M Sell
10,481,842
-697,736
-6% -$7.34M 0.01% 1115
2022
Q4
$139M Sell
11,179,578
-274,592
-2% -$3.4M 0.01% 956
2022
Q3
$119M Buy
11,454,170
+567,365
+5% +$5.88M 0.01% 1008
2022
Q2
$126M Buy
10,886,805
+2,589,738
+31% +$29.9M 0.01% 1012
2022
Q1
$104M Buy
8,297,067
+418,756
+5% +$5.27M 0.01% 1271
2021
Q4
$91.9M Buy
7,878,311
+445,302
+6% +$5.19M ﹤0.01% 1363
2021
Q3
$97.1M Buy
7,433,009
+627,340
+9% +$8.19M 0.01% 1289
2021
Q2
$87.6M Sell
6,805,669
-574,357
-8% -$7.39M ﹤0.01% 1406
2021
Q1
$82.5M Sell
7,380,026
-204,343
-3% -$2.28M ﹤0.01% 1378
2020
Q4
$86.4M Sell
7,584,369
-399,881
-5% -$4.55M 0.01% 1258
2020
Q3
$71.8M Sell
7,984,250
-250,313
-3% -$2.25M ﹤0.01% 1185
2020
Q2
$85M Buy
8,234,563
+2,381,926
+41% +$24.6M 0.01% 1085
2020
Q1
$59.1M Buy
5,852,637
+78,192
+1% +$789K 0.01% 1152
2019
Q4
$76.9M Sell
5,774,445
-52,328
-0.9% -$696K 0.01% 1223
2019
Q3
$50M Sell
5,826,773
-310,639
-5% -$2.67M ﹤0.01% 1440
2019
Q2
$67.1M Sell
6,137,412
-518,598
-8% -$5.67M 0.01% 1288
2019
Q1
$75.4M Buy
6,656,010
+267,006
+4% +$3.03M 0.01% 1200
2018
Q4
$55.4M Sell
6,389,004
-83,275
-1% -$723K 0.01% 1296
2018
Q3
$100M Sell
6,472,279
-139,643
-2% -$2.16M 0.01% 1077
2018
Q2
$106M Sell
6,611,922
-591,564
-8% -$9.47M 0.01% 1001
2018
Q1
$93.1M Buy
7,203,486
+1,438,244
+25% +$18.6M 0.01% 1050
2017
Q4
$72.4M Buy
5,765,242
+338,282
+6% +$4.25M 0.01% 1207
2017
Q3
$71.7M Buy
5,426,960
+17,821
+0.3% +$235K 0.01% 1169
2017
Q2
$85.5M Buy
5,409,139
+651,284
+14% +$10.3M 0.01% 1039
2017
Q1
$68M Buy
4,757,855
+230,972
+5% +$3.3M 0.01% 1142
2016
Q4
$58M Buy
4,526,883
+433,927
+11% +$5.56M 0.01% 1182
2016
Q3
$54.4M Buy
4,092,956
+237,259
+6% +$3.16M 0.01% 1185
2016
Q2
$42.2M Buy
3,855,697
+219,126
+6% +$2.4M ﹤0.01% 1271
2016
Q1
$33.3M Sell
3,636,571
-413,761
-10% -$3.79M ﹤0.01% 1379
2015
Q4
$39.3M Sell
4,050,332
-814,775
-17% -$7.91M ﹤0.01% 1298
2015
Q3
$42.5M Buy
4,865,107
+29,171
+0.6% +$255K ﹤0.01% 1264
2015
Q2
$48.8M Buy
4,835,936
+826,611
+21% +$8.35M 0.01% 1282
2015
Q1
$53.7M Buy
4,009,325
+468,329
+13% +$6.28M 0.01% 1193
2014
Q4
$45.4M Sell
3,540,996
-36,329
-1% -$466K ﹤0.01% 1278
2014
Q3
$38.8M Buy
3,577,325
+254,677
+8% +$2.76M ﹤0.01% 1313
2014
Q2
$42.7M Sell
3,322,648
-436,487
-12% -$5.6M ﹤0.01% 1308
2014
Q1
$38.8M Buy
3,759,135
+223,788
+6% +$2.31M ﹤0.01% 1353
2013
Q4
$34.4M Sell
3,535,347
-167,636
-5% -$1.63M ﹤0.01% 1410
2013
Q3
$36.8M Buy
3,702,983
+119,363
+3% +$1.18M ﹤0.01% 1325
2013
Q2
$29.9M Buy
+3,583,620
New +$29.9M ﹤0.01% 1390